Loss of neurofibromin is considered a tumor-promoting event that leads to RAS hyperactivity and the consequent activation of multiple downstream survival and proliferative pathways, including MAPK, mTOR, and Akt [99]. This evidence concerns the gene MTOR and neoplasm.